Whalesbook
📉 The Financial Deep Dive
Medi Assist Healthcare Services Limited showcased strong top-line growth and significant balance sheet strengthening in its Q3 FY'26 results, announced on February 09, 2026.
The Numbers:
- Consolidated Total Income surged by 29.9% year-on-year in Q3 FY'26, notably boosted by the inclusion of Paramount. For the 9 months ended December 31, 2025, consolidated income grew by a healthy 23.5% YoY. Revenue from contracts saw a 24% YoY increase over the same 9-month period.
- Consolidated EBITDA for the 9 months FY'26 reached INR 128.9 crores, marking a 13.8% YoY growth. The EBITDA margin for Q3 FY'26 improved by 154 basis points (bps) quarter-on-quarter to 18.6%. Excluding the drag from Paramount's integration, EBITDA margins were a robust 21.7% in Q3 FY'26.
- Profit After Tax (PAT) for Q3 FY'26 stood at INR 34.8 crores. However, this figure was impacted by INR 14.2 crores of exceptional items, including a cybersecurity incident at Paramount TPA (INR 3.7 Cr), costs related to labour codes (INR 3.3 Cr), and a provision for disallowed claims (INR 7.1 Cr). Adjusted PAT, excluding these items, was INR 46.3 crores.
The Quality & Balance Sheet:
A major financial highlight is the company achieving a debt-free balance sheet by January 2026. As of December 31, 2025, Medi Assist Healthcare reported a substantial free cash position of INR 200 crores. The company's net worth stood strong at INR 795.7 crores.
Technology revenues demonstrated exceptional growth, climbing 81.5% YoY for the 9-month period and now contributing 2.3% to total revenues. The company's proprietary fraud detection and prevention solution, MAven Guard, proved highly effective, preventing approximately INR 400 crores of fraud in the first 9 months of FY'26, a 66% increase year-on-year.
Management Commentary & Outlook:
Management confirmed that the integration of Paramount is progressing as planned, with the slump transfer of its TPA business to Medi Assist TPA approved and effective February 1, 2026, which is expected to accelerate structural integration. The company is on track to return to its core EBITDA margins post-Paramount integration over the next 2-3 quarters. The strategy includes doubling down on technology deployments and customer acquisition, leveraging the strengthened balance sheet for further growth. The retail segment, ex-Paramount, saw a marginal dip, but overall growth including Paramount was positive. A recovery in the retail segment is also anticipated within 2-3 quarters.
🚩 Risks & Outlook:
The primary short-to-medium term risk lies in the complete integration of Paramount and the normalization of EBITDA margins. While management guidance is positive, execution of planned cost actions and customer retention in the retail segment will be crucial. Investors will be watching the pace of margin recovery and the continued growth in technology revenues and fraud prevention efficiencies.